Skip to main content

Want a detailed portfolio tracker?

Maravai LifeSciences (MRVI) Income Statement (2020 - 2025)

Income Statement report data from Mar 31, 2020 to Sep 30, 2025 for Maravai LifeSciences (MRVI).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Nov 20, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020
Revenue and COGS
Total Revenue
42M
(-12.17%)
47M
(+1.17%)
47M
(-17.17%)
57M
(-18.06%)
69M
(-0.56%)
69M
(+8.16%)
64M
(-13.43%)
74M
(+10.89%)
67M
(-2.97%)
69M
(-12.81%)
79M
(-61.39%)
205M
(+7.03%)
191M
(-21.20%)
243M
(-0.64%)
244M
(+6.94%)
228M
(+11.54%)
205M
(-5.96%)
218M
(+46.94%)
148M
(+50.70%)
98M-185.74M88M
(+87.29%)
47M
(-7.98%)
51M
Cost Of Revenue
36M
(-9.21%)
40M
(+1.28%)
39M
(+5.27%)
37M
(+1.03%)
37M
(-4.64%)
39M
(+0.63%)
38M
(+9.20%)
35M
(-4.31%)
37M
(-15.21%)
43M
(+28.47%)
34M
(-36.75%)
53M
(+39.47%)
38M
(+1.81%)
38M
(-6.32%)
40M
(+2.27%)
39M
(+21.48%)
32M
(-14.78%)
38M
(+20.45%)
31M
(+34.15%)
23M-56.25M20M
(-6.79%)
21M
(+38.56%)
15M
Costof Goods And Services Sold
36M
(-9.21%)
40M
(+1.28%)
39M
(+5.27%)
37M
(+1.03%)
37M
(-4.64%)
39M
(+0.63%)
38M
(+9.20%)
35M
(-4.31%)
37M
(-15.21%)
43M
(+28.47%)
34M
(-36.75%)
53M
(+39.47%)
38M
(+1.81%)
38M
(-6.32%)
40M
(+2.27%)
39M
(+21.48%)
32M
(-14.78%)
38M
(+20.45%)
31M
(+34.15%)
23M-56.25M20M
(-6.79%)
21M
(+38.56%)
15M
Gross Profit
5.66M
(-27.16%)
7.77M
(+0.52%)
7.73M
(-60.13%)
19M
(-39.84%)
32M
(+4.51%)
31M
(+19.35%)
26M
(-33.79%)
39M
(+29.32%)
30M
(+17.71%)
26M
(-43.46%)
45M
(-70.06%)
151M
(-1.06%)
153M
(-25.41%)
205M
(+0.48%)
204M
(+7.90%)
189M
(+9.69%)
173M
(-4.10%)
180M
(+54.05%)
117M
(+55.84%)
75M-129.49M68M
(+164.88%)
26M
(-27.94%)
36M
Operating Expenses
Research And Development
3.84M
(-21.31%)
4.88M
(-0.20%)
4.89M
(+7.24%)
4.56M
(-2.98%)
4.70M
(-4.47%)
4.92M
(-2.19%)
5.03M
(+9.59%)
4.59M
(+5.52%)
4.35M
(+3.82%)
4.19M
(+1.21%)
4.14M
(-17.37%)
5.01M
(-7.05%)
5.39M
(+26.23%)
4.27M
(+15.41%)
3.70M
(-59.69%)
9.18M
(+370.77%)
1.95M
(+1.04%)
1.93M
(-10.65%)
2.16M
(+3.35%)
2.09M-7.21M1.87M
(+16.88%)
1.60M
(-57.22%)
3.74M
Selling General And Administrative
35M
(-8.24%)
39M
(-2.48%)
40M
(-4.07%)
41M
(+5.50%)
39M
(-3.62%)
41M
(-0.81%)
41M
(+6.26%)
38M
(-0.98%)
39M
(+9.84%)
35M
(-8.51%)
39M
(+3.95%)
37M
(+20.78%)
31M
(+9.76%)
28M
(-15.48%)
33M
(+29.79%)
26M
(-3.51%)
27M
(+8.20%)
25M
(+4.39%)
23M
(-43.61%)
42M-52.62M21M
(+28.27%)
16M
(-0.87%)
16M
Operating Expenses
47M
(-58.93%)
114M
(+18.40%)
96M
(-26.74%)
131M
(-33.76%)
198M
(+138.78%)
83M
(-0.22%)
83M
(+2.15%)
81M
(-1.20%)
82M
(+2.17%)
81M
(+5.28%)
76M
(-19.88%)
95M
(+28.39%)
74M
(+19.88%)
62M
(-19.37%)
77M
(+4.10%)
74M
(+49.50%)
49M
(-23.05%)
64M
(+12.66%)
57M
(-15.04%)
67M-97.09M42M
(+8.66%)
39M
(+139.83%)
16M
Depreciation And Amortization
5.98M
(+0.34%)
5.96M
(+4.75%)
5.69M
(+4.02%)
5.47M
(+8.53%)
5.04M
(-9.35%)
5.56M
(+16.08%)
4.79M
(+21.88%)
3.93M
(-3.44%)
4.07M
(+44.33%)
2.82M
(+35.58%)
2.08M
(+6.12%)
1.96M
(+5.38%)
1.86M
(-1.59%)
1.89M
(+1.61%)
1.86M
(+6.29%)
1.75M
(-2.78%)
1.80M
(+11.11%)
1.62M
(+28.57%)
1.26M
(+50.00%)
840K-4.76M1.63M
(+13.99%)
1.43M
(-15.38%)
1.69M
Operating Income
Operating Income
-41.03M
(-38.10%)
-66.28M
(+34.83%)
-49.16M
(+30.40%)
-37.70M
(-77.24%)
-165.61M
(+1132.22%)
-13.44M
(-28.74%)
-18.86M
(+163.78%)
-7.15M
(-53.63%)
-15.42M
(+32.82%)
-11.61M2.53M
(-97.68%)
109M
(-6.54%)
117M
(-35.31%)
181M
(+7.96%)
167M
(+8.30%)
155M
(-0.54%)
155M
(+1.20%)
154M
(+68.37%)
91M
(+191.81%)
31M-88.66M46M
(+463.05%)
8.12M
(-76.68%)
35M
Ebit
-41.03M
(-38.10%)
-66.28M
(+34.83%)
-49.16M
(+30.40%)
-37.70M
(-77.24%)
-165.61M
(+1132.22%)
-13.44M
(-28.74%)
-18.86M
(+163.78%)
-7.15M
(-53.63%)
-15.42M
(+32.82%)
-11.61M2.53M
(-97.68%)
109M
(-6.54%)
117M
(-35.31%)
181M
(+7.96%)
167M
(+8.30%)
155M
(-0.54%)
155M
(+1.20%)
154M
(+68.37%)
91M
(+191.81%)
31M-109.49M46M
(+463.05%)
8.12M
(-76.68%)
35M
EBITDA
-35.06M
(-41.88%)
-60.32M
(+38.76%)
-43.47M
(+34.83%)
-32.24M
(-79.92%)
-160.57M
(+1937.69%)
-7.88M
(-43.99%)
-14.07M
(+336.96%)
-3.22M
(-71.63%)
-11.35M
(+28.98%)
-8.80M4.61M
(-95.85%)
111M
(-6.36%)
119M
(-34.96%)
183M
(+7.90%)
169M
(+8.27%)
156M
(-0.57%)
157M
(+1.31%)
155M
(+67.82%)
92M
(+188.19%)
32M-114.24M47M
(+395.81%)
9.55M
(-73.84%)
37M
Other Income / Expenses
Interest Income
2.80M
(-7.59%)
3.03M
(-6.19%)
3.23M
(-46.52%)
6.04M
(-14.57%)
7.07M
(-0.28%)
7.09M
(-1.66%)
7.21M
(-3.35%)
7.46M
(+0.40%)
7.43M
(+9.43%)
6.79M
(+12.23%)
6.05M
(+158.55%)
2.34M------------
Interest Expense
6.84M
(+0.29%)
6.82M
(+0.59%)
6.78M
(-39.79%)
11M
(-17.39%)
14M
(+14.15%)
12M
(+9.94%)
11M
(-29.48%)
15M
(+32.30%)
12M
(+65.81%)
7.02M
(-40.66%)
12M
(+16.21%)
10M
(+224.20%)
3.14M
(-29.12%)
4.43M
(+66.54%)
2.66M
(-62.11%)
7.02M
(-8.71%)
7.69M
(+0.52%)
7.65M
(-3.16%)
7.90M
(-10.33%)
8.81M-21.93M7.09M
(-4.96%)
7.46M
(+1.08%)
7.38M
Net Interest Income
2.80M
(-7.59%)
3.03M
(-6.19%)
3.23M
(-92.39%)
42M-6.56M
(+35.26%)
-4.85M
(+32.88%)
-3.65M
(-54.03%)
-7.94M
(+89.05%)
-4.20M
(+1726.09%)
-230.00K
(-96.03%)
-5.79M
(-26.15%)
-7.84M
(+149.68%)
-3.14M
(-29.12%)
-4.43M
(+66.54%)
-2.66M
(-62.11%)
-7.02M
(-8.59%)
-7.68M
(+0.39%)
-7.65M
(-3.16%)
-7.90M
(-10.33%)
-8.81M22M-7.09M
(-4.96%)
-7.46M
(+1.08%)
-7.38M
Other Non Operating Income
-70.00K
(-98.28%)
-4.06M20K-2.34M70K-2.56M110K-1.34M70K-1.62M170K-360.00K--1.27M10K
(-96.43%)
280K
(+250.00%)
80K--130K-30K
(+50.00%)
20K-
Net Income
Income Before Tax
-45.15M
(-39.09%)
-74.12M
(+40.67%)
-52.69M
(+14.37%)
-46.07M
(-73.24%)
-172.14M
(+725.61%)
-20.85M
(-6.96%)
-22.41M656M-20.56M
(+53.89%)
-13.36M
(+195.58%)
-4.52M96M
(-15.72%)
114M
(-34.99%)
175M
(+4.88%)
167M
(+15.31%)
145M
(-4.19%)
151M
(+3.52%)
146M
(+63.60%)
89M
(+500.88%)
15M-66.85M39M
(+5585.29%)
680K
(-97.53%)
28M
Income Tax Expense
-90.00K
(-97.90%)
-4.29M160K-10.00K310K-2.43M270K
(-99.96%)
766M-5.46M
(+284.51%)
-1.42M
(-55.21%)
-3.17M8.45M
(-40.11%)
14M
(-22.77%)
18M
(-8.56%)
20M
(+13.65%)
18M
(-6.69%)
19M
(+65.41%)
11M
(-16.92%)
14M
(+3605.41%)
370K-2.51M
(+597.22%)
-360.00K
(-52.63%)
-760.00K3.64M
Net Income From Continuing Operations
-25.56M
(-35.44%)
-39.59M
(+32.23%)
-29.94M
(+15.60%)
-25.90M
(-73.32%)
-97.07M
(+891.52%)
-9.79M
(-18.96%)
-12.08M
(-88.60%)
-105.96M
(+1540.25%)
-6.46M
(-1.22%)
-6.54M
(+9242.86%)
-70.00K38M
(-15.38%)
44M
(-37.58%)
71M
(+6.55%)
67M
(+19.76%)
56M
(+3.47%)
54M
(+9.81%)
49M
(+112.73%)
23M
(-8.37%)
25M-84.59M39M
(+2642.96%)
1.42M
(-93.93%)
23M
Net Income
-25.56M
(-35.44%)
-39.59M
(+32.23%)
-29.94M
(+15.60%)
-25.90M
(-73.32%)
-97.07M
(+891.52%)
-9.79M
(-18.96%)
-12.08M
(-88.60%)
-105.96M
(+1540.25%)
-6.46M
(-1.22%)
-6.54M
(+9242.86%)
-70.00K38M
(-15.38%)
44M
(-37.58%)
71M
(+6.55%)
67M
(+19.76%)
56M
(+3.47%)
54M
(+9.81%)
49M
(+112.73%)
23M
(-8.37%)
25M-84.59M39M
(+2642.96%)
1.42M
(-93.93%)
23M
Comprehensive Income Net Of Tax
-25.55M
(-35.05%)
-39.34M
(+32.82%)
-29.62M
(-79.55%)
-144.85M
(+49.22%)
-97.07M
(+891.52%)
-9.79M
(-18.96%)
-12.08M
(-89.85%)
-119.03M
(+1742.57%)
-6.46M
(-1.22%)
-6.54M
(+9242.86%)
-70.00K220M
(+395.19%)
44M
(-37.58%)
71M
(+6.55%)
67M
(-63.28%)
182M
(+237.19%)
54M
(+9.87%)
49M
(+112.77%)
23M
(-74.02%)
89M-39M
(+2625.87%)
1.43M
(-93.87%)
23M